MorphImmune Inc. — Form D
MorphImmune Inc. of WEST LAFAYETTE, IN, a company, filed a Form D exempt-offering notice with the SEC on 2022-02-17. The offering totals $19.0M, of which $17.1M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-02-17
- Form: D
- Accession: 0001911732-22-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $19.0M
- Amount sold: $17.1M
- Remaining: $1.9M
- Investors: 18
- Date of first sale: 2022-02-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-433947
Issuer
- Name: MorphImmune Inc.
- CIK: 0001911732
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 1281 WIN HENTSCHEL BOULEVARD, WEST LAFAYETTE, IN, 47906
- Phone: 6502384942
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Ronald Martell | Executive Officer | Houston, TX |
| Ronald Martell | Director | Houston, TX |
| Isaac Barchas | Director | Newton, MA |
| Sunil Singhal, M.D. | Director | West Lafayette, IN |
| Philip Low, Ph.D. | Director | West Lafayette, IN |
| Clay B Siegall, Ph.D. | Director | West Lafayette, IN |
| Clay B Siegall, Ph.D. | Executive Officer | West Lafayette, IN |
| Franklyn Prendergast, M.D., Ph.D. | Director | West Lafayette, IN |
Other filings by this issuer (1)
More